Investigations on the pharmacokinetic properties of Harpagophytum extracts and their effects on eicosanoid biosynthesis in vitro and ex vivo

Clinical Pharmacology and Therapeutics

Volumn 69, Issue 5, 2001, Pages 356-364

  Loew, Dieter ^a   Möllerfeld, Jörg ^a   Schrödter, Andreas ^a   Puttkammer, Susanne ^a   Kaszkin, Marietta ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIMYCIN; HARPAGOPHYTUM EXTRACT; HARPAGOSIDE; ICOSANOID; LEUKOTRIENE; PEPTIDOLEUKOTRIENE; THROMBOXANE;

ANTIINFLAMMATORY ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BIOSYNTHESIS; CLINICAL ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALE; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANALGESICS; AREA UNDER CURVE; CYSTEINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOSIDES; HALF-LIFE; HUMANS; INFLAMMATION MEDIATORS; LEUKOTRIENES; MALE; PLANT EXTRACTS; PYRANS; THROMBOXANE B2;

EID: 0035336686     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1067/mcp.2001.115445     Document Type: Article

References (22)

1. Monograph: Harpagophyti radix. BAnz 1989;43:2-3.
2. Monograph: Harpagophyti radix. European Scientific Cooperative on Phytotherapeutics (ESCOP) Proposal for the Summary of Product Characteristics. 2000.
3. Chrubasik S, Zimpfer Ch, Schütz U, Ziegler R. Effectiveness of harpagophytum procumbens in treatment of acute low back pain. Phytomedicine 1996;3:1-10.
4. Chrubasik S, Junck H, Breitschwerdt H, Conradt C, Zappe H. Effectiveness of Harpagophytum extract WS 1531 in the treatment of exacerbation of low back pain: A randomised, placebo-controlled, double-blind study. Eur J Anesthesiol 1999;16:118-29.
5. Göbel H, Heinze A, Ingwersen M, Niederberger U, Gerber D. Wirkmechanismen von Harpagophytum procumbens- Extrakt LI 174 bei der Behandlung von unspezifischen Rückenschmerzen. In: Rietbrock N, editor. Phytopharmaka und Klinische Anwendung; Vol 6. Darmstadt: Steinkopff-Verlag Darmstadt; 2000. p. 99-105.
6. Belaiche P. Etude Clinique de 360 Cas D'arthrose Traites Par le Nebulisat Aqueux d' Harpagophytum Procumbens Phytotherapie 1982;1:22-8.
7. Chantre P, Cappaelare D, Leblan D, Guedon D, Vandermander J, Fournie B. Efficacy and tolerance of Harpagophytum procumbens versus diacerhein in treatment of osteoarthritis. Phytomedicine 2000;7:177-83.
8. Graham R, Robinson BV. Devil's claw (Harpagophytum procumbens): Pharmacological and clinical studies [letter]. Ann Rheum Dis 1981;40:632.
9. Eichler O, Koch C. Über die antiphlogistische, analgetische und spasmolytische Wirksamkeit von Harpagosid, einem Glykosid aus der Wurzel von Harpagophytum procumbens DC. Arzneimittelforschung 1970;20:107-9.
10. Erdös A, Fontaine R, Friehe H, Durand R, Pöppinghaus T. Beitrag zur Pharmakologie und Toxikologie verschiedener Extrakte, sowie des Harpagosids aus Harpagophytum procumbens DC. Planta Med 1978;34:97-108.
11. McLeod DW, REvell R, Robinson BV. Investigations of Harpagophytum procumbens (Devil's Claw) in the treatment of experimental inflammation and arthritis in the rat [proceedings]. Br J Pharmacol 1979;66:140P-1P.
12. Lanhers MC, Fleurentin J, Mortier F, Vinche A, Younos Ch. Anti-inflammatory and analgesic effects of an aqueous extract of Harpagophytum procumbens. Planta Med 1992;58:117-23.
13. Jadot G, Leconte A. Acitivité anti-inflammatoire d'Harpagophytum procumbens DC. Lyon MéDiterrranée MéDical MéDicine du Sud-Est 1992;28:833-5.
14. Soulimani R, Younos C, Mortier F, Derrieu C. The role of stomachal digestion on the pharmacological activity of plant extracts, using as an example extracts of Harpagophytum procumbens. Can J Physiol Pharmacol 1994;72:1532-6.
15. BAghdikian B, Lahners MC, Fluerentin J, Oliver E, Maillard C, Balansard G, et al An analytical study, anti-inflammatory and analgesic effects of Harpagophytum procumbens and Harpagophytum zeyheri. Planta Med 1997;63:171-6.
16. Whitehouse LW, Znamirowska M, Paul CJ. Devil's Claw (Harpagophytum procumbens): No evidence for anti-inflammatory activity in the treatment of arthritic disease. Can Med Assoc J 1983;129:249-51.
17. Tippler B, Syrovets T, Loew D, Simmet T. Harpagophytum procumbens: Wirkung von Extrakten auf die Eicosanoidbiosynthese in Ionophor A23187-stimuliertem menschlichen Vollblut. In: Loew D, Rietbrock N, editors. Phytopharmaka in Forschung und Klinischer Anwendung; II. Darmstadt: Steinkopff-Verlag; 1996. p. 95-100.
18. Tippier B, Syrovets T, Plaza N, Loew D, Simmet T. Harpagophytum procumbens DC used in traditional medicine inhibits eicosanoid biosynthesis in human whole blood. Int J Tissue React 1997;19:101-2.
19. Tippler B, Syrovets T, Loew D, Simmet T. Plasma constituents transform harpagoside into an active principle inhibiting eicosanoid biosynthesis by human blood cells [abstract No. 643]. Naunyn Schmiedebergs Arch Pharmacol 1997.
20. Weide I, Tschorn K, Simmet T. Effects of cyclooxygenase inhibitors on ex vivo cysteinyl-leucotriene production by whole human blood allowed to clot spontaneously. Comparison to stimulated blood. Thromb Res 1992;67: 123-34.
21. Weide I, Tippler B, Syrovets T, Simmet T. Plasmin is a specific stimulus of the 5-lipoxygenase pathway of human peripheral monocytes. Thromb Haemost 1996;76:561-8.
22. Moussard C, Alber D, Toubin MM, Thevenon N, Henry JC. A drug used in traditional medicine, Harpagophytum procumbens: No evidence for NSAID-like effect on whole blood eicosanoid production in human. Prostaglandins Leukot Essent Fatty Acids 1992;46:283-6.